Cardiol Therapeutics Inc (TSE:CRDL) (NASDAQ:CRDL) Stock In Focus After Recent Rally

January 19, 2022

Over the course of the past month, clinical stage life sciences company Cardiol Therapeutics Inc (TSE:CRDL) (NASDAQ:CRDL) has seen its stock emerge as one of the stronger performers in the sector. During that period, the stock attracted significant attention from investors and ended up clocking gains of as much as 30%. Trading Data In the morning session, CRDL stock fell 6.06% to close at $2.17 with more than 416k shares…

Read More >>